Delivery Order SPE2DX15D3021-SPE2DX24F1PG3

Award Date 9/3/24
Potential Completion Date 9/4/24
Potential Value $9.8K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,103.71 firm-fixed-price delivery order is for XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of June 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,184.73 Firm Fixed Price Delivery Order covers the supply of the prescription drug XELJANZ XR 11 MG TABLET. The contract has an ultimate completion date of February 12, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,214.98 firm fixed-price delivery order is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The contract has a period of performance through June 6, 2024 and was not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,552.82 delivery order is for the supply of XELJANZ XR 11 MG TABLET, a specialty medication. This award is a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,234.43 firm fixed-price delivery order is for the supply of XELJANZ XR 11 MG TABLET, a medication used to treat certain medical conditions. The contract has an ultimate completion date of January 15, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,858.28 Firm Fixed Price Delivery Order is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product, with a period of performance through November 29, 2023. This order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4566771243 XELJANZ XR 11 MG TABLET UU 30S. The firm-fixed-price delivery order has a ceiling value of $8,723.07 and a completion date of December 20, 2024. The contract does not have a set-aside designation, indicating an open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of XELJANZ XR 11 MG TABLET in quantities of 30 tablets. The $9,890.97 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense (DoD). The contract has an ultimate completion date of June 6, 2024. Amerisourcebergen, a major pharmaceutical distributor, has a $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,243.13 firm fixed-price delivery order is for the supply of XELJANZ XR 11 MG Tablets, a prescription medication. The contract has an ultimate completion date of June 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,807.89 fixed-price delivery order is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of February 10, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
  • SPE2DX15D3021
    Indefinite Delivery Contract
  • SPE2DX15D3021-SPE2DX24F1PG3
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $9,841.31 firm-fixed-price delivery order is for the supply of 4565663950 XELJANZ XR 11 MG TABLET UU 30S, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a broad range of medical commodities to support military treatment programs and facilities worldwide. Amerisourcebergen has also been awarded another notable IDC by the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs enable government agencies to efficiently procure essential pharmaceutical and medical supplies from Amerisourcebergen, supporting the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 12/3/24, 9:57 AM